The Global Neurorehabilitation Devices Market Is Evolving Around 15.76% Of Cagr By 2027

Triton Market Research presents the Global Neurorehabilitation Devices Market report segmented by Products (Neurorobotic Systems, Brain-Computer Interface, Non-Invasive Stimulators, Wearable Device), its Applications (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson’s Disease, Cerebral Palsy), by End-users (Cognitive Care Centers, Hospitals/Clinics, Research Institutes, Other End-users), by Geographical Region (North America, Europe, Asia Pacific and Rest of World), discussing Industry Value Chain Analysis, Porter's Five Force Analysis, Drivers, Restraints, Vendor Profiles, Global Market Size, Forecasts & Analysis (2019-2027).

Traumatic injuries of the brain, spinal cord or peripheral areas & neuromuscular disorders can affect the patient life drastically. For a better understanding and design formulation, measurement quantification and regulation of the control systems of biomedical devices for treating patients suffering from chronic disorders, the neurorehabilitation devices play a vital role in their solution. Many factors are influencing the market growth, for instance, the growing geriatric population; augmented uptake of both the wearables and rehabilitation robotics; the prevalence of newer cases of neurological diseases; and the innovative developments of the devices. Therefore, Triton Market Research report on global neurorehabilitation devices market depicts that there will be significant development at a compound annual growth rate of approximately 15.76% during the forecast period of 2019-2027.

Instantaneous feedback, passive full body monitoring and further determination of movement analysis, kinetic and kinematic parameters of human movements are quantified through the neurorehabilitation devices. Such utilities permit these devices for taking immediate medical diagnostic steps required upon the occurrence of neurological strokes, where the latter are known to have a higher prevalence rate globally. Thus, more cases of neurological strokes are creating fresher demands for the neurorehabilitation devices market to manufacture robotics implemented rehab-devices that can treat the disabilities caused by the stroke.

According to multiple studies carried out by institutions like the Parkinson’s foundation, National Institute of Health, etc., they found that the number of cases of Parkinson disease and Alzheimer’s disease among the geriatric population of North America has been rising tremendously. As the said population is increasing its size, this will lead to the subsequent rise in adoption of the neurorehabilitation devices in North America.

The global neurorehabilitation devices market has many established companies like Kinestica, Helius Medical Technologies, Neurostyle PTE Ltd., Ectron Limited, Medtronic Inc., Bioxtreme Robotics Rehabilitation, Hocoma AG, Ekso Bionics Holding Inc., St. Jude Medical Inc. and Kinova Robotics where a few of them have collaborated from time to time so as to provide advanced form of training for patients going through mild to medium impairments.